SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-027919
Filing Date
2024-07-16
Accepted
2024-07-15 21:47:55
Documents
2
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 657186
2 formpre14a_001.jpg GRAPHIC 18098
  Complete submission text file 0001493152-24-027919.txt   683431
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37428 | Film No.: 241118472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)